Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
VISEN Pharmaceuticals ( (HK:2561) ) just unveiled an update.
VISEN Pharmaceuticals has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The board also oversees three committees: the Audit Committee, Remuneration Committee, and Nomination Committee, with specific directors assigned as chairpersons and members. This announcement clarifies the governance structure and roles within the company, potentially impacting its strategic direction and stakeholder engagement.
More about VISEN Pharmaceuticals
VISEN Pharmaceuticals is a company incorporated in the Cayman Islands with limited liability, focusing on the pharmaceutical industry.
Average Trading Volume: 56,278
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$5.24B
See more data about 2561 stock on TipRanks’ Stock Analysis page.